- Federal agenciesElevates federal attention to historic injustices in women's health, potentially shaping policy priorities and funding…
- Federal agenciesCould lead to increased federal research investment, creating jobs in medical research and clinical studies.
- Targeted stakeholdersEncourages patient-centered care practices, shared decision-making, and procedural transparency in reproductive and gyn…
Recognizing the United States legacy of dismissed pain and denied autonomy in women's health care, and affirming the Federal Government's duty to protect individual dignity…
Referred to the House Committee on Energy and Commerce.
House Resolution recognizing historical and ongoing injustices in U.S. women’s health care, honoring marginalized women harmed by systemic bias, and affirming principles of patient-centered care, bodily autonomy, expanded research, access to reproductive and gynecological services, and institutional accountability.
The resolution calls for shared decision-making, increased federal investment in women’s health research, and efforts to end normalization of pain in reproductive care.
As a House resolution it is non‑binding and cannot become statutory law; it may pass the House but not create legal obligations.
Relative to its intended legislative type, this bill is a clearly written, non‑binding House resolution whose primary function is recognition and affirmation. It articulates the problem and principle-based commitments succinctly but does not provide implementational mechanics, funding, or accountability structures—features not normally expected in a symbolic resolution.
Liberty/autonomy emphasis versus concern about federal overreach
Who stands to gain, and who may push back.
- Targeted stakeholdersNonbinding resolution that does not itself change law or appropriate funds.
- Federal agenciesMay be used to justify federal intervention in state reproductive policy, risking federal-state legal conflicts.
- Targeted stakeholdersCreates public expectations for new spending or programs without specifying funding sources or timelines.
Why the argument around this bill splits.
Liberty/autonomy emphasis versus concern about federal overreach
Likely strongly supportive: welcomes formal recognition of historic abuses and an explicit federal duty to protect bodily autonomy and expand research.
Would view the resolution as a necessary moral statement and a platform for further policy and funding proposals.
Generally supportive but cautious: endorses recognition of past harms and patient-centered care while preferring precise, evidence-based proposals and clear costings.
Views the resolution as constructive if it leads to targeted, measurable policy and avoids partisan escalation.
Skeptical to opposed: likely views the resolution as a political statement emphasizing abortion and federal expansion of reproductive policy.
While acknowledging past abuses, conservatives will be concerned about federal overreach and lack of protections for conscience and state authority.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House resolution it is non‑binding and cannot become statutory law; it may pass the House but not create legal obligations.
- Whether the resolution will be scheduled for a House floor vote
- Committee consideration and any proposed amendments or substitutions
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberty/autonomy emphasis versus concern about federal overreach
As a House resolution it is non‑binding and cannot become statutory law; it may pass the House but not create legal obligations.
Relative to its intended legislative type, this bill is a clearly written, non‑binding House resolution whose primary function is recognition and affirmation. It articulates the problem and principle-based commitments s…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.